File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Short-form development of the specific module of the QLICD-CRF(V2.0) for assessing the quality of life of patients with chronic renal failure

TitleShort-form development of the specific module of the QLICD-CRF(V2.0) for assessing the quality of life of patients with chronic renal failure
Authors
KeywordsClassical test theory
Generalizability theory
Item response theory
Optimal test assembly
Scale reduction
Issue Date8-Nov-2022
PublisherBioMed Central
Citation
BMC Medical Research Methodology, 2022, v. 22, n. 1 How to Cite?
Abstract

Background

A short instrument would enhance the viability of a study. Therefore, we aimed to shorten the specific module (SPD-10) of the Quality of Life Instrument for Chronic Diseases - Chronic Renal Failure (QLICD-CRF) for assessing the quality of life of patients with chronic renal failure.

Methods

The 10-item SPD-10 was self-administered to 164 patients with chronic renal failure. A shortened form was first obtained by a tandem use of the classical test theory (CTT), the generalizability theory (GT), and the item response theory (IRT). In addition, we also shortened the SPD-10 by the Optimal Test Assembly (OTA).

Results

Both the tandem use of GT, CTT and IRT, and the OTA derived the same 7-item shortened version (SPD-7). It included items CRF1, CRF2, CRF3, CRF4, CRF6, CRF8, and CRF9 of the SPD-10. The SPD-7 had a Cronbach alpha of 0.78. The correlation coefficients of its total and factor scores with those of the SPD-10 were 0.96 and 0.98, respectively. Confirmatory factor analysis confirmed the unidimensional structure of the SPD-7, with the comparative fit index=0.96, the Tucker-Lewis index=0.94, and the root mean square error of approximation=0.09.

Conclusion

The short-form SPD-7 is reliable and valid for assessing the impact of clinical symptoms and side effects on the quality of life of patients with chronic renal failure. It is an efficient option without compromising the measurement performance of the SPD-10.


Persistent Identifierhttp://hdl.handle.net/10722/331501
ISSN
2023 Impact Factor: 3.9
2023 SCImago Journal Rankings: 1.632
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorXiao, Zhengqin-
dc.contributor.authorLiu, Yuxi-
dc.contributor.authorFong, Daniel Yee-Tak-
dc.contributor.authorHuang, Xinping-
dc.contributor.authorWeng, Min-
dc.contributor.authorWan, Chonghua-
dc.date.accessioned2023-09-21T06:56:24Z-
dc.date.available2023-09-21T06:56:24Z-
dc.date.issued2022-11-08-
dc.identifier.citationBMC Medical Research Methodology, 2022, v. 22, n. 1-
dc.identifier.issn1471-2288-
dc.identifier.urihttp://hdl.handle.net/10722/331501-
dc.description.abstract<h3>Background</h3><p>A short instrument would enhance the viability of a study. Therefore, we aimed to shorten the specific module (SPD-10) of the Quality of Life Instrument for Chronic Diseases - Chronic Renal Failure (QLICD-CRF) for assessing the quality of life of patients with chronic renal failure.</p><h3>Methods</h3><p>The 10-item SPD-10 was self-administered to 164 patients with chronic renal failure. A shortened form was first obtained by a tandem use of the classical test theory (CTT), the generalizability theory (GT), and the item response theory (IRT). In addition, we also shortened the SPD-10 by the Optimal Test Assembly (OTA).</p><h3>Results</h3><p>Both the tandem use of GT, CTT and IRT, and the OTA derived the same 7-item shortened version (SPD-7). It included items CRF1, CRF2, CRF3, CRF4, CRF6, CRF8, and CRF9 of the SPD-10. The SPD-7 had a Cronbach alpha of 0.78. The correlation coefficients of its total and factor scores with those of the SPD-10 were 0.96 and 0.98, respectively. Confirmatory factor analysis confirmed the unidimensional structure of the SPD-7, with the comparative fit index=0.96, the Tucker-Lewis index=0.94, and the root mean square error of approximation=0.09.</p><h3>Conclusion</h3><p>The short-form SPD-7 is reliable and valid for assessing the impact of clinical symptoms and side effects on the quality of life of patients with chronic renal failure. It is an efficient option without compromising the measurement performance of the SPD-10.</p>-
dc.languageeng-
dc.publisherBioMed Central-
dc.relation.ispartofBMC Medical Research Methodology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectClassical test theory-
dc.subjectGeneralizability theory-
dc.subjectItem response theory-
dc.subjectOptimal test assembly-
dc.subjectScale reduction-
dc.titleShort-form development of the specific module of the QLICD-CRF(V2.0) for assessing the quality of life of patients with chronic renal failure-
dc.typeArticle-
dc.identifier.doi10.1186/s12874-022-01766-8-
dc.identifier.scopuseid_2-s2.0-85141598558-
dc.identifier.volume22-
dc.identifier.issue1-
dc.identifier.eissn1471-2288-
dc.identifier.isiWOS:000880321300001-
dc.identifier.issnl1471-2288-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats